Total Valuation
China SXT Pharmaceuticals has a market cap or net worth of $2.06M. The enterprise value is -$18.25M.
Market Cap$2.06M
Enterprise Value-$18.25M
Share Statistics
China SXT Pharmaceuticals has 32,218,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,218,080
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China SXT Pharmaceuticals’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -23.11%.
Return on Equity (ROE)-0.21
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-23.11%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee19.15K
Profits Per Employee-110.81K
Employee Count56
Asset Turnover0.03
Inventory Turnover0.30
Valuation Ratios
The current PE Ratio of China SXT Pharmaceuticals is ―. China SXT Pharmaceuticals’s PEG ratio is -0.02.
PE Ratio―
PS Ratio1.06
PB Ratio0.04
Price to Fair Value0.04
Price to FCF-0.28
Price to Operating Cash Flow>-0.01
PEG Ratio-0.02
Income Statement
In the last 12 months, China SXT Pharmaceuticals had revenue of 1.07M and earned -6.21M in profits. Earnings per share was -9.13.
Revenue1.07M
Gross Profit183.28K
Operating Income-7.12M
Pretax Income-6.07M
Net Income-6.21M
EBITDA-6.98M
Earnings Per Share (EPS)-9.13
Cash Flow
In the last 12 months, operating cash flow was -5.15M and capital expenditures -4.00, giving a free cash flow of -5.15M billion.
Operating Cash Flow-5.15M
Free Cash Flow-5.15M
Free Cash Flow per Share-0.16
Dividends & Yields
China SXT Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.98
52-Week Price Change-99.97%
50-Day Moving Average2.00
200-Day Moving Average73.07
Relative Strength Index (RSI)20.54
Average Volume (3m)289.38K
Important Dates
China SXT Pharmaceuticals upcoming earnings date is Feb 1, 2021, Before Open (Confirmed).
Last Earnings DateMar 28, 2019
Next Earnings DateFeb 1, 2021
Ex-Dividend Date―
Financial Position
China SXT Pharmaceuticals as a current ratio of 7.93, with Debt / Equity ratio of 3.77%
Current Ratio7.93
Quick Ratio7.25
Debt to Market Cap0.93
Net Debt to EBITDA3.88
Interest Coverage Ratio-113.13
Taxes
In the past 12 months, China SXT Pharmaceuticals has paid 130.84K in taxes.
Income Tax130.84K
Effective Tax Rate-0.02
Enterprise Valuation
China SXT Pharmaceuticals EV to EBITDA ratio is 3.71, with an EV/FCF ratio of 6.45.
EV to Sales-24.16
EV to EBITDA3.71
EV to Free Cash Flow6.45
EV to Operating Cash Flow6.45
Balance Sheet
China SXT Pharmaceuticals has $28.18M in cash and marketable securities with $1.12M in debt, giving a net cash position of $27.06M billion.
Cash & Marketable Securities$28.18M
Total Debt$1.12M
Net Cash$27.06M
Net Cash Per Share$0.84
Tangible Book Value Per Share$43.70
Margins
Gross margin is 44.37%, with operating margin of -664.06%, and net profit margin of -578.49%.
Gross Margin44.37%
Operating Margin-664.06%
Pretax Margin-566.29%
Net Profit Margin-578.49%
EBITDA Margin-650.71%
EBIT Margin-664.06%
Analyst Forecast
The average price target for China SXT Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-34.63%
EPS Growth Forecast97.52%